Clinical characteristics and immunochemical study of urothelial dysfunction in the patients with interstitial cystitis/bladder pain syndrome with and without hunner's lesion

Clinical characteristics and immunochemical study of urothelial dysfunction in the patients with interstitial cystitis/bladder pain syndrome with and without hunner's lesion

Bibliographic Details
Main Authors:	Jia-Fong Jhang, Hann-Chorng Kuo
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-06-01
Series:	Urological Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S1879522615003577

Similar Items

Urothelial dysfunction and sensory protein expressions in ketamine cystitis – comparision with interstitial cystitis
by: Jia-Fong Jhang, et al.
Published: (2015-06-01)

Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis
by: Yoshiyuki Akiyama, et al.
Published: (2021-01-01)

Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease
by: Jia-Fong Jhang, et al.
Published: (2016-11-01)

Role of serum immunoglobulin E in patients with interstitial cystitis/bladder pain syndrome
by: Jia-Fong Jhang, et al.
Published: (2015-09-01)

Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome
by: Sun Tae Ahn, et al.
Published: (2018-01-01)

Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion
by: Subbroto Kumar Saha, et al.
Published: (2020-06-01)

Proteomic analysis of bladder biopsies from interstitial cystitis/bladder pain syndrome patients with and without Hunner’s lesions reveals differences in expression of inflammatory and structural proteins
by: Elijah P. Ward, et al.
Published: (2020-11-01)

Biomarkers for patients with interstitial cystitis/bladder pain syndrome
by: Hsin-Tzu Liu, et al.
Published: (2015-12-01)

Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition.
by: Jia-Fong Jhang, et al.
Published: (2018-01-01)

Comparative transcriptome analysis of interstitial cystitis/bladder pain syndrome with Hunner lesions and Bacillus Calmette-Guerin related cystitis by next-generation RNA-sequencing: Discovery of disease-specific genes and associated biological pathways
by: Y. Akiyama, et al.
Published: (2020-07-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics
by: Yu Khun Lee, et al.
Published: (2021-08-01)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
by: Yuan-Hong Jiang, et al.
Published: (2021-01-01)

Identification of novel biomarkers in Hunner’s interstitial cystitis using the CIBERSORT, an algorithm based on machine learning
by: Kaining Lu, et al.
Published: (2021-08-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans
by: Yao Chou Tsai, et al.
Published: (2016-09-01)

Histopathological classification of ketamine related cystitis in different bladder condition and the association with treatment outcome
by: Jia-Fong Jhang, et al.
Published: (2016-06-01)

O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome
by: Yuh-Chen Kuo, et al.
Published: (2015-07-01)

Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis.
by: Yuan-Hong Jiang, et al.
Published: (2016-01-01)

Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
by: Cheng-Ling Lee, et al.
Published: (2015-10-01)

Interstitial cystitis: painful bladder syndrome
by: R F Sholan, et al.
Published: (2018-02-01)

Therapeutic effects and predictive factors for successful intravesical hyaluronic acid instillation in patients with interstitial cystitis/bladder pain syndrome
by: Cheng-Ling Lee, et al.
Published: (2015-06-01)

Urothelial dysfunction and chronic inflammation in patients with bladder outlet obstruction and different bladder dysfunction and different BOO degree
by: Cheng-Ling Lee, et al.
Published: (2015-06-01)

Intravesical botulinum toxin-a injections reduce bladder pain of interstitial cystitis/ bladder pain syndrome refractory to conventional treatment – a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Yuan-Hong Jiang, et al.
Published: (2015-06-01)

Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Possible Pathomechanisms and Practical Issues
by: Jia-Fong Jhang
Published: (2019-11-01)

Results of the surgical treatments of ulcer type interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2015-06-01)

Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
by: Yuan-Hong Jiang, et al.
Published: (2014-01-01)

Bladder pain syndrome/interstitial cystitis is associated with hyperthyroidism.
by: Shiu-Dong Chung, et al.
Published: (2013-01-01)

The Evaluation and Management of Interstitial Cystitis/Bladder Pain Syndrome
by: Samantha Kraemer, et al.
Published: (2019-04-01)

Evaluation of Patients with Painful Bladder Syndrome/Interstitial Cystitis
by: Jean Jacques Wyndaele
Published: (2005-01-01)

Animal Model of Interstitial Cystitis/Bladder Pain Syndrome
by: Whi-An Kwon
Published: (2018-01-01)

Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome
by: Lori Birder, et al.
Published: (2018-01-01)

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome
by: Hsiu-Jen Wang, et al.
Published: (2019-11-01)

Bladder Pain Syndrome (Interstitial Cystitis) Consensus 2019: The Report of the Turkish Continence Society Bladder Pain Syndrome/ Interstitial Cystitis Working Group
by: Taner Koçak, et al.
Published: (2020-12-01)

Endoscopic lysis of bladder scar associated with Hunner's lesions: A new technique
by: Sonia Bahlani, et al.
Published: (2015-01-01)

Urothelial dysfunction and sensory protein expressions in patients with urological or systemic diseases and hypersensitive bladder
by: Hueih-Ling Ong, et al.
Published: (2017-09-01)

Biomarkers and Cellular Infiltration of the Bladder in Interstitial Cystitis/Bladder Pain Syndrome
by: Rashad Farkhad ogly Sholan
Published: (2020-09-01)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
by: Luke Grundy, et al.
Published: (2018-12-01)

Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
by: Yuan-Hong Jiang, et al.
Published: (2013-01-01)

Urothelial dysfunction and alternations of sensory protein expressions in bladder mucosa in patients with idiopathic detrusor underactivity
by: Yuan-Hong Jiang, et al.
Published: (2016-06-01)